Asahi Kasei, which recently established its healthcare headquarters in the U.S., now offers Ceolus microcrystalline cellulose (MCC) with nitrite levels of 0.1 μg/g (ppm) or less to contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and nutritional supplements.   In 2018, a potentially carcinogenic nitrosamine impurity was detected in several pharmaceuticals. Since then, public awareness of the potential health hazards of nitrosamine has increa...